4-Methylpiperidine-1-carbonyl Chloride → HCID 11594650, compound
Reaction equation
[N+:1]([C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[NH:9][N:8]=[C:7]2[OH:13])([O-:3])=[O:2].[CH3:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21](Cl)=[O:22])[CH2:17][CH2:16]1>N1C=CC=CC=1>[CH3:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21]([O:13][C:7]2[C:6]3[C:10](=[CH:11][CH:12]=[C:4]([N+:1]([O-:3])=[O:2])[CH:5]=3)[NH:9][N:8]=2)=[O:22])[CH2:17][CH2:16]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
200 mg (1.12 mmol) of 5-nitro-1H-indazol-3-ol and 180.4 mg (1.67 mmol) of 4-methylpiperidine-1-carbonyl chloride (Example 2) in 20 ml of pyridin were heated under reflux for 5 h and left to stand overnight. Pyridine was distilled off in vacuo, and the residue was dissolved in water and extracted with ethyl acetate. The organic phase was concentrated and purified by preparative HPLC (PR18, acetonitrile/water 0.1% TFA). Yield: 48 mg (14%), M+H+: 304.99.
Workup
- temperatureunder reflux for 5 h
- waitleft
- distillationPyridine was distilled off in vacuo
- dissolutionthe residue was dissolved in water
- extractionextracted with ethyl acetate
- concentrationThe organic phase was concentrated
- custompurified by preparative HPLC (PR18, acetonitrile/water 0.1% TFA)
Sources & evidence
- ORD record
- ord-ab4cdad33a9c4cbca48267dbe3edb95f
- Source dataset
- uspto-grants-2011_06
- Patent number
- US07968719B2
Reaction notes
Loading…